img

Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Research Report 2024

Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.
According to Mr Accuracy reports’s new survey, global Dipeptide Peptidase 4 (DPP-4) Inhibitors market is projected to reach US$ 10840 million in 2034, increasing from US$ 8984.2 million in 2024, with the CAGR of 2.3% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dipeptide Peptidase 4 (DPP-4) Inhibitors market research.
Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dipeptide Peptidase 4 (DPP-4) Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Eli Lilly
AstraZenica
Boehringer Ingelheim
Takeda Pharmaceutical Company
BMS
Segment by Type
Sitagliptin
Saxagliptin
Linagliptin
Alogliptin
Vildagliptin

Segment by Application


Hospitals
Clinics

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Dipeptide Peptidase 4 (DPP-4) Inhibitors report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Overview
1.1 Product Overview and Scope of Dipeptide Peptidase 4 (DPP-4) Inhibitors
1.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Type
1.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value Comparison by Type (2024-2034)
1.2.2 Sitagliptin
1.2.3 Saxagliptin
1.2.4 Linagliptin
1.2.5 Alogliptin
1.2.6 Vildagliptin
1.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Application
1.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue 2018-2034
1.4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales 2018-2034
1.4.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competition by Manufacturers
2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Price by Manufacturers (2018-2023)
2.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Product Type & Application
2.7 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competitive Situation and Trends
2.7.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dipeptide Peptidase 4 (DPP-4) Inhibitors Players Market Share by Revenue
2.7.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Retrospective Market Scenario by Region
3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region: 2018-2034
3.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region: 2018-2023
3.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region: 2024-2034
3.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region: 2018-2034
3.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region: 2018-2023
3.3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region: 2024-2034
3.4 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.4.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.4.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.5.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.5.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.6.3 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.7.3 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.8.3 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2018-2034)
4.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2018-2023)
4.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2024-2034)
4.1.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2018-2034)
4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2018-2034)
4.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2018-2023)
4.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2024-2034)
4.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2018-2034)
4.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2018-2034)
5 Segment by Application
5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2018-2034)
5.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2018-2023)
5.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2024-2034)
5.1.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2018-2034)
5.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2018-2034)
5.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2018-2023)
5.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2024-2034)
5.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2018-2034)
5.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 AstraZenica
6.3.1 AstraZenica Corporation Information
6.3.2 AstraZenica Description and Business Overview
6.3.3 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.3.5 AstraZenica Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Takeda Pharmaceutical Company
6.5.1 Takeda Pharmaceutical Company Corporation Information
6.5.2 Takeda Pharmaceutical Company Description and Business Overview
6.5.3 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.5.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.6 BMS
6.6.1 BMS Corporation Information
6.6.2 BMS Description and Business Overview
6.6.3 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.6.5 BMS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Chain Analysis
7.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Mode & Process
7.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales and Marketing
7.4.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Channels
7.4.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors
7.5 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers
8 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Dynamics
8.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Trends
8.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Drivers
8.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Challenges
8.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptide Peptidase 4 (DPP-4) Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2018-2023) & (K Units)
Table 18. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2018-2023)
Table 19. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2024-2034) & (K Units)
Table 20. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2024-2034)
Table 21. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2018-2023)
Table 23. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2024-2034)
Table 25. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2018-2023) & (K Units)
Table 27. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2024-2034) & (K Units)
Table 28. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2018-2023) & (K Units)
Table 32. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2024-2034) & (K Units)
Table 33. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) by Type (2018-2023)
Table 51. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) by Type (2024-2034)
Table 52. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2018-2023)
Table 53. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2024-2034)
Table 54. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2018-2023)
Table 57. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2024-2034)
Table 58. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2018-2023)
Table 59. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2024-2034)
Table 60. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) by Application (2018-2023)
Table 61. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) by Application (2024-2034)
Table 62. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2018-2023)
Table 63. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2024-2034)
Table 64. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2018-2023)
Table 67. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2024-2034)
Table 68. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2018-2023)
Table 69. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 74. Merck Recent Developments/Updates
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. AstraZenica Corporation Information
Table 81. AstraZenica Description and Business Overview
Table 82. AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 84. AstraZenica Recent Developments/Updates
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Takeda Pharmaceutical Company Corporation Information
Table 91. Takeda Pharmaceutical Company Description and Business Overview
Table 92. Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 94. Takeda Pharmaceutical Company Recent Developments/Updates
Table 95. BMS Corporation Information
Table 96. BMS Description and Business Overview
Table 97. BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 99. BMS Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors List
Table 103. Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers List
Table 104. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Trends
Table 105. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Drivers
Table 106. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Challenges
Table 107. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dipeptide Peptidase 4 (DPP-4) Inhibitors
Figure 2. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Type in 2024 & 2034
Figure 4. Sitagliptin Product Picture
Figure 5. Saxagliptin Product Picture
Figure 6. Linagliptin Product Picture
Figure 7. Alogliptin Product Picture
Figure 8. Vildagliptin Product Picture
Figure 9. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Application in 2024 & 2034
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size (2018-2034) & (US$ Million)
Figure 15. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (2018-2034) & (K Units)
Figure 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Price (USD/Unit) & (2018-2034)
Figure 17. Dipeptide Peptidase 4 (DPP-4) Inhibitors Report Years Considered
Figure 18. Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Manufacturers in 2024
Figure 19. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest Dipeptide Peptidase 4 (DPP-4) Inhibitors Players: Market Share by Revenue in 2024
Figure 21. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 22. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 23. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2018-2034)
Figure 24. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2018-2034)
Figure 25. U.S. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2018-2034)
Figure 28. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2018-2034)
Figure 29. Germany Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2018-2034)
Figure 36. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Taiwan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Philippines Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2018-2034)
Figure 47. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. U.A.E Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Type (2018-2034)
Figure 57. Global Revenue Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Type (2018-2034)
Figure 58. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application (2018-2034)
Figure 60. Global Revenue Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application (2018-2034)
Figure 61. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2018-2034)
Figure 62. Dipeptide Peptidase 4 (DPP-4) Inhibitors Value Chain
Figure 63. Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries